Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation
暂无分享,去创建一个
[1] P. Zhu,et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. , 2011, Human gene therapy.
[2] I. Maričić,et al. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. , 2011, Gastroenterology.
[3] K. Abdi,et al. Antigen‐Activated T Cells Induce IL‐12p75 Production from Dendritic Cells in an IFN‐γ‐Independent Manner , 2010, Scandinavian journal of immunology.
[4] S. Robson,et al. Transgenic Overexpression of CD39 Protects Against Renal Ischemia‐Reperfusion and Transplant Vascular Injury , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] E. Podrez,et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands , 2010, Nature.
[6] P. Kubes,et al. Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.
[7] B. Ke,et al. Programmed death‐1/B7‐H1 negative costimulation protects mouse liver against ischemia and reperfusion injury , 2010, Hepatology.
[8] Xiu‐da Shen,et al. Alloimmune Activation Enhances Innate Tissue Inflammation/Injury in a Mouse Model of Liver Ischemia/Reperfusion Injury , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] R. Schnellmann,et al. Murine Kupffer Cells Are Protective in Total Hepatic Ischemia/Reperfusion Injury with Bowel Congestion through IL-10 , 2010, The Journal of Immunology.
[10] D. Candinas,et al. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice , 2010, Hepatology.
[11] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[12] G. Plitas,et al. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. , 2010, Journal of Clinical Investigation.
[13] G. Plitas,et al. Toll‐like receptor 9 inhibition confers protection from liver ischemia–reperfusion injury , 2010, Hepatology.
[14] C. Leclerc,et al. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.
[15] Yanghua Qin,et al. HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products1 , 2009, The Journal of Immunology.
[16] Zhang Jinxiang,et al. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. , 2009, Biochemical and biophysical research communications.
[17] F. Gao,et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury , 2009, Hepatology.
[18] M. Crow,et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. , 2009, Kidney international.
[19] U. Andersson,et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation , 2009, Journal of leukocyte biology.
[20] R. Flavell,et al. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation , 2009, Nature Immunology.
[21] J. Emond,et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. , 2009, Journal of hepatology.
[22] A. Lentsch,et al. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[23] I. N. Crispe,et al. The liver as a lymphoid organ. , 2009, Annual review of immunology.
[24] Haitao Wen,et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events , 2008, The Journal of experimental medicine.
[25] B. Engelhardt,et al. Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines , 2008, Hepatology.
[26] Zhigang Tian,et al. Liver: An organ with predominant innate immunity , 2007, Hepatology.
[27] F. Gao,et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury , 2007, Hepatology.
[28] M. Rosengart,et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.
[29] C. Müller,et al. CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Provides Myocardial Protection During Cardiac Ischemia/Reperfusion Injury , 2007, Circulation.
[30] A. Lentsch,et al. Lymphocyte function during hepatic ischemia/reperfusion injury , 2007, Journal of leukocyte biology.
[31] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[32] M. Lotze,et al. Increasing numbers of hepatic dendritic cells promote HMGB1‐mediated ischemia‐reperfusion injury , 2007, Journal of leukocyte biology.
[33] Courtney M. Lappas,et al. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation , 2006, The Journal of experimental medicine.
[34] F. Krombach,et al. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets , 2006, Hepatology.
[35] M. Lotze,et al. Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.
[36] F. Gao,et al. Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[37] Ryan M. O’Connell,et al. Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.
[38] M. Bilodeau,et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia‐warm reperfusion of the rat liver , 2004, Hepatology.
[39] J. Emond,et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice , 2004, Hepatology.
[40] R. Busuttil,et al. Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.
[41] F. Sallusto,et al. Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. , 2003, Pathologie-biologie.
[42] F. Gao,et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO‐1 dependence of Stat4 disruption‐mediated cytoprotection , 2003, Hepatology.
[43] A. Lentsch,et al. Endogenous IL‐13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury , 2003, Hepatology.
[44] A. Lentsch,et al. Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6 , 2000, Inflammation Research.
[45] M. Miyazaki,et al. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. , 1999, The American journal of pathology.
[46] J. M. Henderson,et al. Liver transplantation and rejection: an overview. , 1999, Hepato-gastroenterology.
[47] G. Gerken,et al. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. , 1995, Journal of hepatology.
[48] M. Shimada,et al. Ischemic injury in liver transplantation: Difference in injury sites between warm and cold ischemia in rats , 1992, Hepatology.
[49] J. Cofer,et al. The influence of preservation injury on rejection in the hepatic transplant recipient. , 1990, Transplantation.